Dr. Ramakrishna Venkatesh, MD

Dr. Venkatesh practices at St. Luke's Hospital in Chesterfield, Missouri, part of St. Luke's Episcopal-Presbyterian Hospital.

Dr. Venkatesh's NPI, 1548286768, was assigned on July 14, 2006. Dr. Venkatesh holds Missouri license 2004000458.

Dr. Venkatesh's primary practice is St. Luke's Hospital, at 232 S Woods Mill Rd, Chesterfield, MO 63017 in St. Louis County. The practice phone is (314) 434-1500.

Dr. Venkatesh's primary practice is St. Luke's Hospital in Chesterfield, Missouri, part of St. Luke's Episcopal-Presbyterian Hospital. Dr. Venkatesh is also affiliated with Mercy Hospital Springfield. The medical group on file is Mercy Clinic Family Medicine - Hollister. Dmand AI also links Dr. Venkatesh to 2 more hospitals, 5 medical groups, 3 group practices and clinics and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Venkatesh practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Venkatesh's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Venkatesh's licenses on file in 2 states: Missouri and Illinois.

CMS data shows 186 Medicare services from Dr. Venkatesh across 9 procedure codes in 2024, for 115 Medicare patients. Medicare paid $15,679 for them.

CMS counts 115 Medicare patients who saw Dr. Venkatesh in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Venkatesh's median patient age at 73, with 31% women.

In 2024, Dr. Venkatesh wrote 388 Medicare Part D claims for 160 patients. 98% of them were for generic drugs. CMS names the drug for 297 of them, across 8 drugs with 11 or more claims each, at $3,384 in total drug cost. In 2023, CMS named 478 claims across 11 drugs.

Dr. Venkatesh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of prostate resection by Dr. Venkatesh, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 20 papers to Dr. Venkatesh, published from 2019 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Nephrectomy, Kidney Neoplasms and Kidney Calculi. Dr. Venkatesh has published most often in J Endourol. Dr. Venkatesh's most frequent co-authors are Robert S. Figenshau, MD, Eric Kim, DDS, MD and Sam B. Bhayani, MD.

CMS Open Payments shows 104 general payments to Dr. Venkatesh from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 37% of the total. Travere Therapeutics, Inc. paid the most, $5,146.